Correlation Between Bio Path and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Bio Path and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Zura Bio Limited, you can compare the effects of market volatilities on Bio Path and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Zura Bio.
Diversification Opportunities for Bio Path and Zura Bio
Very weak diversification
The 3 months correlation between Bio and Zura is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Bio Path i.e., Bio Path and Zura Bio go up and down completely randomly.
Pair Corralation between Bio Path and Zura Bio
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Zura Bio. But the stock apears to be less risky and, when comparing its historical volatility, Bio Path Holdings is 1.99 times less risky than Zura Bio. The stock trades about -0.05 of its potential returns per unit of risk. The Zura Bio Limited is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 816.00 in Zura Bio Limited on September 3, 2024 and sell it today you would lose (511.00) from holding Zura Bio Limited or give up 62.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 86.87% |
| Values | Daily Returns |
Bio Path Holdings vs. Zura Bio Limited
Performance |
| Timeline |
| Bio Path Holdings |
| Zura Bio Limited |
Bio Path and Zura Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Zura Bio
The main advantage of trading using opposite Bio Path and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Zura Bio vs. DiaMedica Therapeutics | Zura Bio vs. Lyra Therapeutics | Zura Bio vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world |